This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeay, S. Articles by Sonenshein, G. E. Search for Related Content PubMed PubMed Citation Articles by Jeay, S. Articles by Sonenshein, G. E.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2003, p. 2251-2263, Vol. 23, No. 7
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.7.2251-2263.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-B

Department of Biochemistry, Boston University Medical School, Boston, Massachusetts 02118,

Received 25 July 2002/ Returned for modification 28 October 2002/ Accepted 3 January 2003

Lysyl oxidase (LO), which catalyzes the oxidation of lysine residues, was previously shown to have anti-oncogenic activity on ras-transformed cells. Since oncogenic Ras mediates transformation, in part, through the activation of the transcription factor nuclear factor-B (NF-B), we tested here the effects of LO on NF-B activity. Expression of LO in ras-transformed NIH 3T3 cells led to decreased NF-B binding and activity, as well as the expression of the NF-B target gene c-myc. Importantly, ectopic expression of LO led to a dramatic decrease in colony formation by ras-transformed NIH 3T3 cells, a finding comparable to the expression of the IB dominant-negative mutant, which could be rescued by p65/p50 NF-B subunit expression. LO was unable to directly inhibit the activity of ectopically expressed p65 and c-Rel NF-B subunits, suggesting that LO affected an upstream signaling pathway(s) induced by Ras. Consistent with this hypothesis, LO expression decreased both the rate of IB turnover and the activities of IKK and IKKß. Moreover, the ectopic expression of a constitutively active version of either kinase reversed the negative effects of LO. Ras can induce NF-B via both the phosphatidylinositol 3-kinase (PI3K)/Akt and Raf/MEK pathways. LO potently downregulated the PI3K and Akt kinases, while partially inhibiting MEK kinase activity. Expression of a constitutively activated, myristylated Akt or PDK1 was able to counteract the effect of LO on NF-B, whereas constitutively activated Raf was only partially effective. Importantly, LO blocked membrane localization of Akt and PDK1 in Ras-transformed cells. Overall, these results strongly argue that the anti-oncogenic effects of LO on ras-mediated transformation are due to its ability to inhibit signaling pathways that lead to activation of NF-B.

This article has been cited by other articles:

• Wu, M., Min, C., Wang, X., Yu, Z., Kirsch, K. H., Trackman, P. C., Sonenshein, G. E. (2007). Repression of BCL2 by the Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Inhibits Transformed Phenotype of Lung and Pancreatic Cancer Cells. Cancer Res. 67: 6278-6285 [Abstract] [Full Text]  
• Guo, Y., Pischon, N., Palamakumbura, A. H., Trackman, P. C. (2007). Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells. Am. J. Physiol. Cell Physiol. 292: C2095-C2102 [Abstract] [Full Text]  
• Pearn, L., Fisher, J., Burnett, A. K., Darley, R. L. (2007). The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood 109: 4461-4469 [Abstract] [Full Text]  
• Min, C., Kirsch, K. H., Zhao, Y., Jeay, S., Palamakumbura, A. H., Trackman, P. C., Sonenshein, G. E. (2007). The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu-Driven Breast Cancer. Cancer Res. 67: 1105-1112 [Abstract] [Full Text]  
• Guo, S., Lu, J., Subramanian, A., Sonenshein, G. E. (2006). Microarray-Assisted Pathway Analysis Identifies Mitogen-Activated Protein Kinase Signaling as a Mediator of Resistance to the Green Tea Polyphenol Epigallocatechin 3-Gallate in Her-2/neu-Overexpressing Breast Cancer Cells.. Cancer Res. 66: 5322-5329 [Abstract] [Full Text]  
• Bouez, C., Reynaud, C., Noblesse, E., Thepot, A., Gleyzal, C., Kanitakis, J., Perrier, E., Damour, O., Sommer, P. (2006). The Lysyl Oxidase LOX Is Absent in Basal and Squamous Cell Carcinomas and Its Knockdown Induces an Invading Phenotype in a Skin Equivalent Model. Clin. Cancer Res. 12: 1463-1469 [Abstract] [Full Text]  
• Cavin, L. G., Wang, F., Factor, V. M., Kaur, S., Venkatraman, M., Thorgeirsson, S. S., Arsura, M. (2005). Transforming Growth Factor-{alpha} Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-{kappa}B in Murine Hepatocellular Carcinomas. Mol Cancer Res 3: 403-412 [Abstract] [Full Text]  
• Guo, S., Sonenshein, G. E. (2004). Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway. Mol. Cell. Biol. 24: 8681-8690 [Abstract] [Full Text]  
• Palamakumbura, A. H., Jeay, S., Guo, Y., Pischon, N., Sommer, P., Sonenshein, G. E., Trackman, P. C. (2004). The Propeptide Domain of Lysyl Oxidase Induces Phenotypic Reversion of Ras-transformed Cells. J. Biol. Chem. 279: 40593-40600 [Abstract] [Full Text]  
• Kaneda, A., Wakazono, K., Tsukamoto, T., Watanabe, N., Yagi, Y., Tatematsu, M., Kaminishi, M., Sugimura, T., Ushijima, T. (2004). Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers. Cancer Res. 64: 6410-6415 [Abstract] [Full Text]  
• Hanson, J. L., Anest, V., Reuther-Madrid, J., Baldwin, A. S. (2003). Oncoprotein Suppression of Tumor Necrosis Factor-induced NF{kappa}B Activation Is Independent of Raf-controlled Pathways. J. Biol. Chem. 278: 34910-34917 [Abstract] [Full Text]  
• Palamakumbura, A. H., Sommer, P., Trackman, P. C. (2003). Autocrine Growth Factor Regulation of Lysyl Oxidase Expression in Transformed Fibroblasts. J. Biol. Chem. 278: 30781-30787 [Abstract] [Full Text]